AJU IB Investment Co., Ltd. - Q4 2020 holdings

$264 Million is the total value of AJU IB Investment Co., Ltd.'s 11 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .

 Value Shares↓ Weighting
AVIR NewATEA PHARMACEUTICALS INC$85,621,0002,049,331
+100.0%
32.40%
APLS NewAPELLIS PHARMACEUTICALS INC$63,776,0001,114,962
+100.0%
24.13%
SEER NewSEER INC$59,866,0001,066,375
+100.0%
22.66%
KYMR NewKYMERA THERAPEUTICS INC$43,652,000704,059
+100.0%
16.52%
STRO NewSUTRO BIOPHARMA$3,799,000175,000
+100.0%
1.44%
CLSD NewCLEARSIDE BIOMEDICAL INC$2,174,000793,555
+100.0%
0.82%
RAPT NewRAPT THERAPEUTICS INC$2,143,000108,503
+100.0%
0.81%
MTEM NewMOLECULAR TEMPLATES INC$1,923,000204,809
+100.0%
0.73%
KZR NewKEZAR LIFE SCIENCES INC$673,000128,916
+100.0%
0.26%
ALRN NewAILERON THERAPEUTICS INC$538,000517,558
+100.0%
0.20%
NewBELLICUM PHARMACEUTICALS INC$91,00025,651
+100.0%
0.03%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KYMERA THERAPEUTICS INC8Q3 202240.4%
SEER INC8Q3 202225.9%
RAPT THERAPEUTICS INC8Q3 20225.1%
SUTRO BIOPHARMA INC8Q3 20223.6%
ATEA PHARMACEUTICALS INC4Q3 202147.7%
APELLIS PHARMACEUTICALS INC4Q3 202138.8%
RALLYBIO CORP4Q3 202218.7%
XILIO THERAPEUTICS INC4Q3 202214.9%
CLEARSIDE BIOMEDICAL INC4Q3 20211.1%
MOLECULAR TEMPLATES INC4Q3 20211.0%

View AJU IB Investment Co., Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-HR/A2022-11-14
13F-HR2022-11-07
13F-HR2022-08-09
13F-HR2022-05-12
13F-HR2022-02-09
13F-HR2021-11-10
13F-HR2021-08-10
13F-HR2021-05-12
13F-HR2021-05-12
42017-11-13

View AJU IB Investment Co., Ltd.'s complete filings history.

Compare quarters

Export AJU IB Investment Co., Ltd.'s holdings